Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the ...

Janssen filed patent infringement suits in New Jersey and Delaware over proposed copy of blockbuster drug Invega Sustenna | Lawsuits follow appeals court win for J&J in separate action with Teva and ...

Johnson & Johnson JNJ will begin the earnings season for the drug & biotech sector when it reports its second-quarter 2025 ...

J&J(JNJ) wins U.S. appeals court case protecting its Invega Sustenna patent from generic rivals Viatris (VTRS) & Teva (TEVA).

Teva's lawsuit was filed on Jan. 15, two days before the company's Austedo/Austedo XR (deutetrabenazine) was included in CMS' latest list of drugs subject to price negotiation.

Teva Pharmaceuticals challenges the Inflation Reduction Act, arguing CMS's drug pricing policies harm generics, biosimilars, and innovation, disrupting healthcare balance.

The settlement with Teva Pharmaceuticals comes one week before the city’s opioid lawsuit is set to go to trial.

Teva and DOJ May Reach Settlement in Closely Watched AKS Lawsuit On June 16, Teva Pharmaceuticals filed a request with the First Circuit Court of Appeals seeking to hold in abeyance its ...

Teva Pharmaceutical is negotiating with the DOJ to settle a lawsuit alleging it paid kickbacks through charities to boost Copaxone sales, risking up to $10 billion in damages.

The lawsuit said Corcept and specialty pharmacy Optime Care, the sole distributor of Korlym, orchestrated “a multifaceted scheme to prolong Corcept’s monopoly by stifling competition from Teva ...

The lawsuit follows an Abbreviated New Drug Application filed by Teva Pharmaceuticals, Inc., which seeks authorization from the FDA to manufacture, use or sell a generic version of mitomycin for ...